Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care

Vera A. de Vries*, Marcella C. A. Mueller, M. Sesmu Arbous, Bart J. Biemond, Nicole Blijlevens, Nuray Kusadasi, Lambert R. F. Span, Alexander P. J. Vlaar, David J. van Westerloo, Hanneke C. Kluin-Nelemans, Walter M. van den Bergh, Pieter Roel Tuinman, Angelique Spoelstra, Erik Marijt, Nicole Blijlevens, Murielle Hilkens, Jelle Epker, Annoek Broers, Goda Choi, Astrid DemandtWalther van Mook, HEMA-ICU Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E120-E128
Number of pages9
JournalCritical Care Medicine
Volume47
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • hematologic malignancy
  • intensive care unit
  • multiple organ failure/mortality
  • organ failure
  • prognosis
  • CRITICALLY-ILL PATIENTS
  • CANCER-PATIENTS
  • PROGNOSTIC-FACTORS
  • UNIT
  • ADMISSION
  • SEVERITY
  • CHEMOTHERAPY
  • SURVIVAL
  • IMPACT
  • GROUPE

Cite this

de Vries, V. A., Mueller, M. C. A., Arbous, M. S., Biemond, B. J., Blijlevens, N., Kusadasi, N., Span, L. R. F., Vlaar, A. P. J., van Westerloo, D. J., Kluin-Nelemans, H. C., van den Bergh, W. M., Tuinman, P. R., Spoelstra, A., Marijt, E., Blijlevens, N., Hilkens, M., Epker, J., Broers, A., Choi, G., ... HEMA-ICU Study Grp (2019). Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care. Critical Care Medicine, 47(2), E120-E128. https://doi.org/10.1097/CCM.0000000000003526